Functional Antibodies in COVID-19 Convalescent Plasma

In the absence of an effective vaccine or monoclonal therapeutic, transfer of convalescent plasma (CCP) was proposed early in the SARS-CoV-2 pandemic as an easily accessible therapy. However, despite the global excitement around this historically valuable therapeutic approach, results from CCP trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Herman, Jonathan D., Wang, Chuangqi, Loos, Carolin, Yoon, Hyunah, Rivera, Johanna, Dieterle, M. Eugenia, Haslwanter, Denise, Jangra, Rohit K., Bortz, Robert H., Bar, Katharine J., Julg, Boris, Chandran, Kartik, Lauffenburger, Douglas, Pirofski, Liise-anne, Alter, Galit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987034/
https://www.ncbi.nlm.nih.gov/pubmed/33758875
http://dx.doi.org/10.1101/2021.03.08.21253157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987034/
https://www.ncbi.nlm.nih.gov/pubmed/33758875
http://dx.doi.org/10.1101/2021.03.08.21253157

Ejemplares similares